OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 23 filers reported holding OPIANT PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $10,000 | -23.1% | 1,400 | -4.6% | 0.00% | -100.0% |
Q2 2020 | $13,000 | -7.1% | 1,467 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $14,000 | -54.8% | 1,467 | -32.1% | 0.00% | 0.0% |
Q4 2019 | $31,000 | -79.5% | 2,162 | -81.3% | 0.00% | -88.9% |
Q1 2019 | $151,000 | -56.9% | 11,533 | -52.3% | 0.01% | -60.9% |
Q4 2018 | $350,000 | – | 24,197 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 80,000 | $850,000 | 0.77% |
PERRITT CAPITAL MANAGEMENT INC | 32,000 | $340,000 | 0.18% |
Newbridge Financial Services Group, Inc. | 5,300 | $56,000 | 0.04% |
Mesirow Financial Investment Management, Inc. | 753 | $8,000 | 0.02% |
Marquette Asset Management, LLC | 7,941 | $84,000 | 0.02% |
Renaissance Technologies | 222,815 | $2,366,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 59,831 | $635,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 10,400 | $110,000 | 0.00% |
American Research & Management Co. | 300 | $3,000 | 0.00% |
Certified Advisory Corp | 500 | $5,000 | 0.00% |